Silverarc Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-248,347
| Closed | -$1.69K | – | 83 |
|
|
2022
Q1 | $1.69K | Buy |
248,347
+2,518
| +1% | +$17 | 0.7% | 34 |
|
|
2021
Q4 | $2.05M | Buy |
245,829
+37,270
| +18% | +$311K | 0.83% | 38 |
|
|
2021
Q3 | $1.55M | Sell |
208,559
-42,085
| -17% | -$313K | 0.88% | 40 |
|
|
2021
Q2 | $1.7K | Sell |
250,644
-99,356
| -28% | -$675 | 0.76% | 46 |
|
|
2021
Q1 | $3.6M | Sell |
350,000
-56,665
| -14% | -$582K | 1.96% | 17 |
|
|
2020
Q4 | $2.85M | Buy |
+406,665
| New | +$2.85M | 1.65% | 21 |
|